Cat: IPD-X28502

Recombinant Human HSP90B1 Protein,Strep & His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    HSP90B1

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    GRP94; HSPC4; TRA1

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    N-His;N-StrepⅡ

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    P14625

  • 表达区间

    R43-K754

  • 蛋白长度

    Partial

  • 分子量

    85.5 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

HSP90B1, also known as heat shock protein 90 beta, is a key molecular chaperone that plays a crucial role in protein folding, stability, and maturation within the cell. This protein is particularly important in the endoplasmic reticulum (ER), where it assists in the proper folding of glycoproteins and maintains cellular homeostasis under stress conditions. Over the years, research has shown that dysregulation of HSP90B1 is associated with various diseases, including cancer and neurodegenerative disorders, making it a significant target for therapeutic interventions. The recombinant expression of HSP90B1 allows for the study of its structural properties, functional mechanisms, and interactions with other proteins. Such studies are essential for understanding its role in disease pathways and developing potential drugs that can modulate its activity. Additionally, recombinant HSP90B1 can be utilized in biotechnological applications, including vaccine development and the production of therapeutic proteins. This highlights the importance of characterizing HSP90B1 to unravel its multifaceted biological roles and its potential implications in health and disease. Researchers are focused on optimizing expression systems and purification methods to obtain functional HSP90B1, which will facilitate further studies into its chaperone activity and its effects on protein aggregation and misfolding. Ultimately, a deeper understanding of HSP90B1 could lead to novel strategies for disease treatment and prevention, capitalizing on its pivotal role in cellular protein homeostasis.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US